Zacks Analyst Blog Highlights: Wright Medical Group, Inc., Zimmer Holdings Inc., Stryker Corp., Johnson & Johnson and Smith & Nephew plc.

For Immediate Release

Chicago, IL – November 2, 2009 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Wright Medical Group, Inc. (WMGI - Analyst Report), Zimmer Holdings Inc. (ZMH - Analyst Report), Stryker Corp. (SYK - Analyst Report), Johnson & Johnson (JNJ - Analyst Report) and Smith & Nephew plc. (SNN - Snapshot Report).

Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=5513

Here are highlights from Friday’s AnalystBlog:

Wright Eclipses Zacks Estimate

Wright Medical Group, Inc. (WMGI - Analyst Report) reported third-quarter earnings per share of 19 cents, surpassing the Zacks Consensus Estimate of 9 cents. The company had earned 19 cents per share in the year-ago quarter.

Wright has provided guidance for the fourth quarter and fiscal 2009. For the fourth quarter, net sales are estimated between $122 and $127 million, representing an increase of roughly 2% to 6% from the year-ago period. Earnings per share is expected in the range of 22 to 26 cents.

For fiscal 2009, net sales should range between $480 and $485 million, increasing approximately 3% to 4% year over year. Earnings per share should be in the range of 80 to 84 cents.

Wright Medical is a global orthopedic devices company specializing in the design, manufacture, and marketing of reconstructive joint devices and bio-orthopedic materials. The orthopedic industry is highly competitive, and Wright Medical faces challenges from large players, such as Zimmer Holdings Inc. (ZMH - Analyst Report), Stryker Corp. (SYK - Analyst Report), Johnson & Johnson/De Puy (JNJ - Analyst Report), Smith & Nephew plc. (SNN - Snapshot Report) and Biomet.

Want more from Zacks Equity Research? Subscribe to the free Profit from the Pros newsletter: http://at.zacks.com/?id=5515.

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.

Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today: http://at.zacks.com/?id=5517

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at http://at.zacks.com/?id=5518.

Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Follow us on Twitter: http://twitter.com/zacksresearch

Join us on Facebook: http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts

Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.

Contact:
Mark Vickery
Web Content Editor
312-265-9380
Visit: www.zacks.com

Read the full analyst report on WMGI

Read the full analyst report on ZMH

Read the full analyst report on SYK

Read the full analyst report on JNJ

Read the full analyst report on SNN